Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04961242 · ClinicalTrials.gov registry record

Pilot Evaluation of Together for Wellness Website in COVID-19

A clinical trial, sponsored by University of California, Los Angeles.

Completed
Registry status
315
Enrollment target

NCT04961242: Completed study, sponsored by University of California, Los Angeles.

NCT04961242 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 315 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04961242 has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
315 participants
Enrollment target

Study Summary

This is a pilot evaluation of a set of free digital mental health resources developed for COVID-19 relief in California, with funding for the evaluation by the California Health Care Foundation. The website includes resources to support information on COVID-19, meditation and stress management, resources for parenting resilience, resources for social connection and addressing structural racism, and linkages to resources under the partnering "CalHOPE" website (FEMA funded). The evaluation includes: 1) an invitation from a partnering agency to visit the website and consider the evaluation; 2) a post website visit baseline survey; 3) a follow-up survey 4-6 weeks later; 4) a telephone interview for a subset of participants who agree to the follow-up interview and provide their contact information.

Primary Outcome

Screener for depressive disorder

Interventions

  • DEVICE Together for Wellness digital mental health website

Trial Details

FieldValue
Enrollment Target 315 participants
Start Date 2021-09-20
Est. Completion 2023-01-07

What the finished NCT04961242 record still lists

NCT04961242 is an observational study that tracks outcomes without assigning an intervention. The registered 315 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Together for Wellness digital mental health website is the first listed.

NCT04961242 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04961242 about?

NCT04961242 is a clinical study titled "Pilot Evaluation of Together for Wellness Website in COVID-19". This is a pilot evaluation of a set of free digital mental health resources developed for COVID-19 relief in California, with funding for the evaluation by the California Health Care Foundation. The website includes resources to support information on COVID-19, meditation and stress management, reso...

What is the current status of trial NCT04961242?

This trial is currently completed. The enrollment target is 315 participants. The study started on 2021-09-20. Estimated completion is 2023-01-07.

What interventions are being tested in trial NCT04961242?

The interventions under investigation include: Together for Wellness digital mental health website (DEVICE).

Who is sponsoring clinical trial NCT04961242?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04812366 · 315 participants · Phase 2

    Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

  • NCT05101460 · 315 participants

    An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant

  • NCT05897320 · 315 participants · Phase 3

    A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

  • NCT06439082 · 315 participants · Phase 3

    A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04961242, the US trial registry maintained by the National Library of Medicine. NCT04961242 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.